Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Human Genetics
|
June 1, 1995
Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient
P R Hoban, J Heighway, G R White, et al.
Human Molecular Genetics
|
November 1, 1995
Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3
M Stack, D Jones, G White, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours
M Gugger, A Kappeler, S Vonlanthen, et al.
British Journal of Cancer
|
January 1, 1997
Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy
J M Appleby, J B Barber, E Levine, et al.
British Journal of Cancer
|
August 26, 2004
METH-2 silencing and promoter hypermethylation in NSCLC
J R Dunn, D Panutsopulos, M W Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
C Matthias, K Branigan, V Jahnke, et al.
British Journal of Cancer
|
October 14, 2005
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
S L Smith, N L Bowers, D C Betticher, et al.
British Journal of Cancer
|
December 1, 1994
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53
J M Birch, J Heighway, M D Teare, et al.
Oncogene
|
December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
S Vonlanthen, J Heighway, M P Tschan, et al.
Cancer Letters
|
April 24, 2007
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
O Gautschi, B Huegli, A Ziegler, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Human Genetics
|
June 1, 1995
Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient
P R Hoban, J Heighway, G R White, et al.
Human Molecular Genetics
|
November 1, 1995
Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3
M Stack, D Jones, G White, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 12, 2001
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours
M Gugger, A Kappeler, S Vonlanthen, et al.
British Journal of Cancer
|
January 1, 1997
Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy
J M Appleby, J B Barber, E Levine, et al.
British Journal of Cancer
|
August 26, 2004
METH-2 silencing and promoter hypermethylation in NSCLC
J R Dunn, D Panutsopulos, M W Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
C Matthias, K Branigan, V Jahnke, et al.
British Journal of Cancer
|
October 14, 2005
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
S L Smith, N L Bowers, D C Betticher, et al.
British Journal of Cancer
|
December 1, 1994
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53
J M Birch, J Heighway, M D Teare, et al.
Oncogene
|
December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
S Vonlanthen, J Heighway, M P Tschan, et al.
Cancer Letters
|
April 24, 2007
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
O Gautschi, B Huegli, A Ziegler, et al.
Page
of 5